Log In
BCIQ
Print this Print this
 

S-707106

  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionOral insulin sensitizer
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today